Methylpred

# METHYLPRED ## Overview - **Classification**: Glucocorticoid, Corticosteroid - **Mechanism**: Binds to intracellular glucocorticoid receptors, modulating gene expression to produce potent anti-inflammatory and immunosuppressive effects. ## Primary Indications 1. **Inflammatory & Allergic Conditions** - e.g., severe asthma, allergic reactions, dermatologic conditions 2. **Immunosuppression** - e.g., autoimmune diseases (lupus, rheumatoid arthritis), organ transplant rejection 3. **Acute Exacerbations** - e.g., Multiple Sclerosis (MS), Chronic Obstructive Pulmonary Disease (COPD) ## Adult Dosing ### Standard Dosing **Anti-inflammatory/Immunosuppressive** - **Dose**: **4-48 mg** - **Frequency**: Once daily or in divided doses - **Route**: PO, IV, IM - **Duration**: Varies based on condition, often tapered for chronic use **Acute Multiple Sclerosis Exacerbation** - **Dose**: **160 mg** PO - **Frequency**: Once daily for 7 days, then **64 mg** every other day for 1 month - **Route**: PO - **Alternatively (Pulse)**: **1000 mg** IV daily for 3-5 days **Acute COPD Exacerbation** - **Dose**: **32 mg** PO - **Frequency**: Once daily - **Route**: PO - **Duration**: 5 days ### Dose Adjustments - **Renal Impairment**: No specific dose adjustment generally needed. - **Hepatic Impairment**: Caution advised; monitor for increased steroid effects as metabolism may be impaired. - **Elderly Patients**: No specific dose adjustment but monitor for increased susceptibility to adverse effects (e.g., osteoporosis, hyperglycemia). ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: **0.2-0.8 mg/kg/day** - **Frequency**: Divided every 6-12 hours - **Maximum**: Depends on indication; use lowest effective dose. - **Special Notes**: Use with extreme caution due to high risk of adverse effects (HTN, hyperglycemia, HPA axis suppression). ### Infants (1-12 months) - **Dose**: **0.16-0.8 mg/kg/day** - **Frequency**: Divided every 6-24 hours - **Maximum**: **80 mg/day** (anti-inflammatory) - **Special Notes**: Oral liquid formulation often preferred. ### Children (1-12 years) - **Anti-inflammatory/Immunosuppressive** - **Dose**: **0.16-0.8 mg/kg/day** - **Frequency**: Divided every 6-24 hours - **Maximum**: **80 mg/day** - **Acute Asthma Exacerbation** - **Dose**: **1 mg/kg/dose** (Max **60 mg**) - **Frequency**: Every 6-12 hours for 48 hours, then once daily - **Pulse Therapy (e.g., severe asthma, transplant)** - **Dose**: **15-30 mg/kg/dose** (Max **1000 mg/dose**) - **Frequency**: Once daily for 3-5 days ### Adolescents (13-18 years) - **Dose**: Generally follow adult dosing recommendations. - **Maximum**: Adult maximum doses (e.g., **1000 mg/dose** for pulse therapy). ## Safety Information ### Contraindications - **Absolute**: Systemic fungal infections - **Absolute**: Known hypersensitivity to methylprednisolone - **Absolute**: Live or live-attenuated vaccines when on immunosuppressive doses - **Relative**: Active untreated infections (except when life-threatening) ### Common Adverse Effects - **Very Common (>10%)**: Hyperglycemia, increased appetite, insomnia, fluid retention, mood changes, increased blood pressure - **Common (1-10%)**: Headache, dyspepsia, acne, muscle weakness, impaired wound healing - **Serious but Rare**: Adrenal suppression, osteoporosis (long-term), cataracts, glaucoma, GI perforation, avascular necrosis ### Key Drug Interactions - **CYP3A4 Inducers (e.g., Phenytoin, Rifampin)**: Decreased methylprednisolone levels; may require dose increase. - **CYP3A4 Inhibitors (e.g., Ketoconazole, Macrolides)**: Increased methylprednisolone levels; monitor for toxicity, may require dose reduction. - **NSAIDs**: Increased risk of GI bleeding and ulceration; co-administration should be cautious. - **Anticoagulants (e.g., Warfarin)**: Effects can be variable; monitor INR closely. - **Antidiabetic Agents**: May increase blood glucose; monitor glucose levels and adjust antidiabetic dose as needed. ## Monitoring & Follow-up - **Before Treatment**: Baseline blood pressure, weight, electrolytes, glucose, signs of infection. - **During Treatment**: Blood pressure, weight, glucose (especially in diabetics), electrolytes (K, Na), signs of infection. - **Long-Term Treatment**: Bone mineral density, HPA axis function (e.g., morning cortisol), ophthalmic exams (for cataracts/glaucoma). - **Clinical Signs**: Watch for signs of infection, fluid retention, mood changes, muscle weakness, stomach upset. ## Clinical Pearls - 💡 **Tapering**: For treatment longer than 5-7 days, gradually taper the dose to prevent adrenal insufficiency. - 💡 **Administration**: Take oral doses with food or milk to minimize GI upset. - 💡 **Infection Risk**: Patients on steroids are at increased risk of infection; counsel to report fever or new symptoms. - 💡 **Bone Health**: For long-term use, consider calcium/vitamin D supplementation and bisphosphonates to mitigate osteoporosis risk. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.